Doctor profile · Federal record
Dr. Jonathan Schwartz, M.D.
Hematology & Oncology Physician · Hematology (Internal Medicine) Physician · Tucson, AZ
- NPI 1437101755
- MIPS 99.7 / 100 · 2023
- 20 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3945 E Paradise Falls Dr Ste 105
Tucson, AZ 857126686
(520) 689-7008
fax (520) 230-3310 - Mailing address
-
3945 E Paradise Falls Dr Ste 201
Tucson, AZ 857126687
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- October 5, 2022
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #14175
- Medicaid
- AZ #267931
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437101755. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,414
Distinct HCPCS
10
Medicare allowed
$1,321,682
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,700 | 11 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 16,200 | 17 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 10,140 | 68 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,934 | 47 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,080 | 34 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 820 | 31 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 501 | 284 | $89 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 312 | 148 | $125 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 291 | 68 | $128 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 255 | 54 | $28 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 951. This provider delivers 53× the peer median.Open Payments
Industry payments received
All-time total
$1,448
Transactions
37
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $598.20 | |
| AstraZeneca Pharmaceuticals LP | 6 | $116.36 | |
| Janssen Biotech, Inc. | 4 | $91.96 | |
| Daiichi Sankyo Inc. | 3 | $73.45 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $60.61 | |
| Genentech USA, Inc. | 2 | $58.12 | |
| GENZYME CORPORATION | 2 | $52.92 | |
| PFIZER INC. | 3 | $51.83 | |
| Sumitomo Pharma America, Inc. | 2 | $43.88 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40.13 | |
| TerSera Therapeutics LLC | 1 | $31.79 | |
| Celgene Corporation | 1 | $28.75 | |
| SOBI, INC | 1 | $27.08 | |
| Fresenius Kabi USA, LLC | 1 | $26.47 | |
| Blueprint Medicines Corporation | 1 | $24.49 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
747
Patients
187
Total drug cost
$1,524,203
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 154 | 36 | $3,728 |
| Hydroxyurea | Generic | 62 | 14 | $2,917 |
| Dexamethasone | Generic | 61 | 25 | $1,145 |
| Letrozole | Generic | 55 | 13 | $1,553 |
| Prednisone | Generic | 51 | 19 | $326 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 46 | 21 | $886 |
| Ondansetron Hcl | Generic | 45 | 26 | $580 |
| Acyclovir | Generic | 44 | 0 | $883 |
| Exemestane | Generic | 41 | 0 | $5,076 |
| Revlimid (Lenalidomide) | Brand | 38 | 0 | $793,806 |
Frequently asked questions
What is Dr. Jonathan Schwartz's medical specialty?
Dr. Jonathan Schwartz practices Hematology & Oncology Physician in Tucson, AZ.
Where does Dr. Jonathan Schwartz practice?
Dr. Jonathan Schwartz practices at 3945 E Paradise Falls Dr Ste 105, Tucson, AZ 857126686. Office phone: 5206897008.
What is Dr. Jonathan Schwartz's NPI?
Dr. Jonathan Schwartz's National Provider Identifier (NPI) is 1437101755, issued by NPPES.
What procedures does Dr. Jonathan Schwartz commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.